Wird geladen...
Ondansetron Exposure Changes in a Pregnant Woman
Pregnancy results in many physiologic changes that can alter the pharmacokinetic profiles of medications used during pregnancy. One of the primary factors leading to these pharmacokinetic changes is altered activity of drug-metabolizing enzymes. Ondansetron is a substrate of cytochrome P450 (CYP) 3A...
Gespeichert in:
| Veröffentlicht in: | Pharmacotherapy |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5738660/ https://ncbi.nlm.nih.gov/pubmed/27374186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1796 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|